CU23256A1 - EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS - Google Patents

EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS

Info

Publication number
CU23256A1
CU23256A1 CU20030062A CU20030062A CU23256A1 CU 23256 A1 CU23256 A1 CU 23256A1 CU 20030062 A CU20030062 A CU 20030062A CU 20030062 A CU20030062 A CU 20030062A CU 23256 A1 CU23256 A1 CU 23256A1
Authority
CU
Cuba
Prior art keywords
carbon atoms
prostatitis
fatty acids
free fatty
extract obtained
Prior art date
Application number
CU20030062A
Other languages
English (en)
Spanish (es)
Inventor
Canavaciolo Victor Lu Gonzalez
Cuevas Vivian Molina
Leyes Eduardo Antoni Rodriguez
Quinatana Daisy Carbajal
Granja Abilio Melquiade Laguna
Ferreiro Rosa Maria Mas
Valmana Maria De Arruzazabala
Original Assignee
Dalmer Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40210497&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU23256(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dalmer Lab Sa filed Critical Dalmer Lab Sa
Priority to CU20030062A priority Critical patent/CU23256A1/es
Priority to AU2004222693A priority patent/AU2004222693B2/en
Priority to MXPA05009905A priority patent/MXPA05009905A/es
Priority to JP2006504216A priority patent/JP4693766B2/ja
Priority to HK06105583.6A priority patent/HK1084059B/en
Priority to DE602004013572T priority patent/DE602004013572D1/de
Priority to DK04720576T priority patent/DK1623740T3/da
Priority to ES04720576T priority patent/ES2306999T3/es
Priority to RU2005130746/15A priority patent/RU2331434C2/ru
Priority to AT04720576T priority patent/ATE394139T1/de
Priority to BRPI0409056-0A priority patent/BRPI0409056A/pt
Priority to NZ542361A priority patent/NZ542361A/xx
Priority to CA2519410A priority patent/CA2519410C/en
Priority to EP04720576A priority patent/EP1623740B1/en
Priority to PCT/CU2004/000004 priority patent/WO2004082696A1/es
Priority to CNB2004800071887A priority patent/CN100366246C/zh
Priority to UAA200508900A priority patent/UA82224C2/uk
Priority to US10/549,740 priority patent/US20060228429A1/en
Priority to PT04720576T priority patent/PT1623740E/pt
Priority to KR1020057017600A priority patent/KR100758256B1/ko
Priority to ZA200507575A priority patent/ZA200507575B/xx
Priority to CR8001A priority patent/CR8001A/es
Priority to EC2005006028A priority patent/ECSP056028A/es
Priority to IL170997A priority patent/IL170997A/en
Priority to NO20054847A priority patent/NO333290B1/no
Publication of CU23256A1 publication Critical patent/CU23256A1/es
Priority to US12/575,575 priority patent/US20100021574A1/en
Priority to US12/575,584 priority patent/US20100022649A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CU20030062A 2003-03-20 2003-03-20 EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS CU23256A1 (es)

Priority Applications (27)

Application Number Priority Date Filing Date Title
CU20030062A CU23256A1 (es) 2003-03-20 2003-03-20 EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS
KR1020057017600A KR100758256B1 (ko) 2003-03-20 2004-03-15 로이스토네아 레기아 (대왕 야자) 과일로부터 얻어지는 약제학적 조성물과 상기 약제학적 조성물을 얻는 방법
CA2519410A CA2519410C (en) 2003-03-20 2004-03-15 Pharmaceutical composition and procedure to treat and prevent prostatic hyperplasia and prostatitis from the royal palm (roystonea regia) fruits
PCT/CU2004/000004 WO2004082696A1 (es) 2003-03-20 2004-03-15 Composición farmacéutica y procedimiento para el tratamiento y prevención de la hiperplasia prostática y la prostatitis a partir de los frutos de roystones regia (palma real)
JP2006504216A JP4693766B2 (ja) 2003-03-20 2004-03-15 ローヤル・パーム（Ｒｏｙｓｔｏｎｅａｒｅｇｉａ）果実由来の薬剤組成物並びに前立腺肥大および前立腺炎を治療および予防する方法
HK06105583.6A HK1084059B (en) 2003-03-20 2004-03-15 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits
DE602004013572T DE602004013572D1 (de) 2003-03-20 2004-03-15 Pharmazeutische zusammensetzung und verfahren zur behandlung und prävention von prostatahyperplasie und prostatitis unter verwendung von früchten von roystonea regia (königspalme)
DK04720576T DK1623740T3 (da) 2003-03-20 2004-03-15 Farmaceutisk sammensætning og metode til behandling af og forebyggelse mod prostatahyperplasi og prostatitis under anvendelse af frugter og Roystonea regis (kongepalme)
ES04720576T ES2306999T3 (es) 2003-03-20 2004-03-15 Composicion farmaceutica y procedimiento para el tratamiento y prevencion de hiperplasia prostatica y prostatitis usando los frutos de roystonea regia (palmera real).
RU2005130746/15A RU2331434C2 (ru) 2003-03-20 2004-03-15 Лекарственный препарат, получаемый из плодов королевской пальмы (roystonea regia), и способ его применения для лечения и профилактики простатической гиперплазии и простатита
AT04720576T ATE394139T1 (de) 2003-03-20 2004-03-15 Pharmazeutische zusammensetzung und verfahren zur behandlung und prävention von prostatahyperplasie und prostatitis unter verwendung von früchten von roystonea regia (königspalme)
BRPI0409056-0A BRPI0409056A (pt) 2003-03-20 2004-03-15 composição farmacêutica de roystonea regia para tratar e previnir a hiperplasia da próstata e prostatite e método de obtenção da composição farmacêutica de roystonea regia para tratar e prevenir a hiperplasia da próstata e prostatite
NZ542361A NZ542361A (en) 2003-03-20 2004-03-15 Pharmaceutical composition and procedure to treat and prevent prostatic hyperplasia and prostatitis from the royal palm (Roystonea regia) fruits
AU2004222693A AU2004222693B2 (en) 2003-03-20 2004-03-15 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using Roystonea regia (royal palm) fruits
EP04720576A EP1623740B1 (en) 2003-03-20 2004-03-15 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits
MXPA05009905A MXPA05009905A (es) 2003-03-20 2004-03-15 Composicion farmaceutica y procedimiento para el tratamiento y prevencion de la hiperplasia prostatica y la prostatitis a partir de los frutos de roystones regia (palma real).
CNB2004800071887A CN100366246C (zh) 2003-03-20 2004-03-15 来源于王棕(Roystonea regia)果实的用于治疗和预防前列腺增生和前列腺炎的药物组合物及方法
UAA200508900A UA82224C2 (uk) 2003-03-20 2004-03-15 Фармацевтична композиція з плодів королівської пальми (roystonea regia) для лікування і попередження гіперплазії передміхурової залози та простатиту і спосіб її приготування
US10/549,740 US20060228429A1 (en) 2003-03-20 2004-03-15 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits
PT04720576T PT1623740E (pt) 2003-03-20 2004-03-15 Método e composição farmacológicos para o tratamento e prevenção da hiperplasia prostática e prostatite, utilizando frutos de roystonea regia (palmeira real)
ZA200507575A ZA200507575B (en) 2003-03-20 2005-09-19 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using Roystonea regia (Royal Palm) fruits
CR8001A CR8001A (es) 2003-03-20 2005-09-20 Composicion farmaceutica y procedimiento para el tratamiento y prevencion de la hiperplasia prostatica y la prostatitis a partir de los frutos de roystonea regia (palma real)
EC2005006028A ECSP056028A (es) 2003-03-20 2005-09-20 Composición farmacéutica y procedimiento para el tratamiento y prevención de la hiperplasia prostática y la prostatitis a partir de los frutos de roystonea regia
IL170997A IL170997A (en) 2003-03-20 2005-09-20 Pharmaceutical composition for treatment and prevention of prostatic hyperplasia and prostatitis from the royal palm (roystonea regia) fruits and the process for preparation thereof
NO20054847A NO333290B1 (no) 2003-03-20 2005-10-20 Farmasoytisk sammensetning for behandling og forebygging av prostatisk hyperplasi og prostatitt ved a anvende frukter av roystonea regia kongepalme.
US12/575,575 US20100021574A1 (en) 2003-03-20 2009-10-08 Pharmaceutical Composition and Procedure to Treat and Prevent Prostatic Hyperplasia and Prostatitis from the Royal Palm (Roystonea regia) Fruits
US12/575,584 US20100022649A1 (en) 2003-03-20 2009-10-08 Pharmaceutical Composition and Procedure to Treat and Prevent Prostatic Hyperplasia and Prostatitis From the Royal Palm (Roystonea regia) Fruits

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20030062A CU23256A1 (es) 2003-03-20 2003-03-20 EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS

Publications (1)

Publication Number Publication Date
CU23256A1 true CU23256A1 (es) 2008-01-24

Family

ID=40210497

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20030062A CU23256A1 (es) 2003-03-20 2003-03-20 EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS

Country Status (24)

Country Link
US (3) US20060228429A1 (enExample)
EP (1) EP1623740B1 (enExample)
JP (1) JP4693766B2 (enExample)
KR (1) KR100758256B1 (enExample)
CN (1) CN100366246C (enExample)
AT (1) ATE394139T1 (enExample)
AU (1) AU2004222693B2 (enExample)
BR (1) BRPI0409056A (enExample)
CA (1) CA2519410C (enExample)
CR (1) CR8001A (enExample)
CU (1) CU23256A1 (enExample)
DE (1) DE602004013572D1 (enExample)
DK (1) DK1623740T3 (enExample)
EC (1) ECSP056028A (enExample)
ES (1) ES2306999T3 (enExample)
IL (1) IL170997A (enExample)
MX (1) MXPA05009905A (enExample)
NO (1) NO333290B1 (enExample)
NZ (1) NZ542361A (enExample)
PT (1) PT1623740E (enExample)
RU (1) RU2331434C2 (enExample)
UA (1) UA82224C2 (enExample)
WO (1) WO2004082696A1 (enExample)
ZA (1) ZA200507575B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4926395B2 (ja) * 2004-11-30 2012-05-09 学校法人 名城大学 抗ｍｒｓａ用組成物
KR100769412B1 (ko) * 2006-09-13 2007-10-22 주식회사 벤스랩 Ｐｒ-119 복합생약 추출물을 함유하는 전립선 비대증의예방 및 치료용조성물
WO2010118362A1 (en) 2009-04-09 2010-10-14 The Regents Of The University Of Colorado, A Body Corporate Methods and compositions for inducing physiological hypertrophy
CU24143B1 (es) * 2012-06-19 2016-01-29 Cnic Ct Nac Investigaciones Ingrediente activo para el tratamiento y la prevención de la inflamación y el estrés oxidativo, así como su procedimiento de obtención a partir de los frutos de acrocomina crispa y/o acrocomia aculeata
CA2957363C (en) * 2014-08-12 2022-06-21 Institut de Recherche en Semiochimie et Ethologie Appliquee Palmitoleic acid for use in inhibiting the attachment of sea lice to fish
KR102273967B1 (ko) * 2014-10-31 2021-07-08 (주)아모레퍼시픽 인삼씨유를 함유하여 전립선 비대증을 예방 및 치료하는 조성물
JP2017214342A (ja) * 2016-06-02 2017-12-07 日清オイリオグループ株式会社 排尿障害の予防用又は改善用組成物
JP6628946B2 (ja) 2017-12-26 2020-01-15 大太朗 福岡 増毛、頭皮若しくは皮膚の改質、創傷治癒、骨形成促進、または毛髪の改質に用いるための医薬組成物
AU2019212513B2 (en) 2018-01-26 2024-10-31 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion
EP4082518A1 (en) 2021-04-28 2022-11-02 Cnce Innovacion, S.L. Fatty acid compositions for the treatment and prevention of hair loss and alopecia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU21519A1 (en) * 1983-03-23 1987-06-09 Inst De Quimica Y Biolog Ex Procedure to facilitate the grinding of roystonea regia fruits
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
CN1184670A (zh) * 1997-12-23 1998-06-17 张冰 一种治疗前列腺增生、前列腺炎的药物组合物
RU2140265C1 (ru) * 1998-10-27 1999-10-27 Чернобаев Николай Евгеньевич Средство для лечения и профилактики доброкачественной гиперплазии простаты (дгп), простатита, импотенции, бесплодия и рака предстательной железы

Also Published As

Publication number Publication date
RU2005130746A (ru) 2006-06-10
ECSP056028A (es) 2006-01-27
DE602004013572D1 (de) 2008-06-19
CN100366246C (zh) 2008-02-06
AU2004222693B2 (en) 2010-08-12
US20100022649A1 (en) 2010-01-28
HK1084059A1 (en) 2006-07-21
KR20050115920A (ko) 2005-12-08
ATE394139T1 (de) 2008-05-15
MXPA05009905A (es) 2006-03-21
UA82224C2 (uk) 2008-03-25
CA2519410A1 (en) 2004-09-30
JP2006520331A (ja) 2006-09-07
US20100021574A1 (en) 2010-01-28
KR100758256B1 (ko) 2007-09-13
AU2004222693A2 (en) 2004-09-30
NO20054847L (no) 2005-10-20
IL170997A (en) 2010-04-15
EP1623740A1 (en) 2006-02-08
PT1623740E (pt) 2008-08-12
ES2306999T3 (es) 2008-11-16
CN1761476A (zh) 2006-04-19
US20060228429A1 (en) 2006-10-12
CA2519410C (en) 2011-04-26
BRPI0409056A (pt) 2006-03-28
EP1623740B1 (en) 2008-05-07
JP4693766B2 (ja) 2011-06-01
CR8001A (es) 2006-04-21
DK1623740T3 (da) 2008-09-08
ZA200507575B (en) 2007-03-28
WO2004082696A1 (es) 2004-09-30
NO333290B1 (no) 2013-04-29
NZ542361A (en) 2009-10-30
AU2004222693A1 (en) 2004-09-30
RU2331434C2 (ru) 2008-08-20

Similar Documents

Publication Publication Date Title
CU23256A1 (es) EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS
MXPA03010183A (es) Proceso para preparar acidos carboxilicos y derivados de los mismos.
Shalmashi Ultrasound‐assisted extraction of oil from tea seeds
PT906381E (pt) Processo para a producao de um objecto a base de parafina e objecto a base de parafina
GB2352724B (en) A novel process for preparing fine extracts and oils from plants and other matter
MXPA02008280A (es) Sistema y metodo para producir fluoruro de 18f.
MY145320A (en) Process for producing dioleoyl palmitoyl glyceride
Maier et al. Combined use of vibrational spectroscopy and GC–MS methods in the characterization of archaeological pastes from Patagonia
DE60119711D1 (de) Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen
EP1591417A4 (en) METHOD FOR CHOOSING THE STRUCTURE OF CARBON NANOTUBES BY LIGHT EMITTING
ECSP077247A (es) Trans - clomifeno para el tratamiento de la hipertrofia prostatica benigna, cancer prostatico, hipogonodismo, trigliceridos elevados y alto colesterol
DE59401321D1 (de) Verfahren zur Gewinnung von pharmakologisch wirksamen Verbindungen aus komplexen Stoffgemischen
BR9810581B1 (pt) processos para a remoção de espécie formaldeìdo de uma mistura orgánica lìquida e para a produção de metacrilato de metila.
EE9900008A (et) Mittehüdraatuvate fosfatiidide madala sisaldusega glütseriidõli tootmismeetod
NO983050D0 (no) Stabilisering av pigmenter og flerumettede oljer
DE69708338D1 (de) Verfahren zur herstullung natürlicher 1,3 diol derivate und korrespondierende natürliche 1,3 dioxan derivate
Maier et al. Characterization of reference lipids and their degradation products by Raman spectroscopy, nuclear magnetic resonance and gas chromatography-mass spectrometry
ATE257842T1 (de) Verfahren zur gewinnung von 17beta-(n-tert- butylcarbamoyl)-3-on-4-aza-steroiden
YU6200A (sh) Postupak za proizvodnju diestara 2,3,5-trimetilhidrohinona
ATE325174T1 (de) Verfahren zur herstellung von photolumineszenten polarisatoren
ATE376047T1 (de) Verfahren zur herstellung von konjugierten fettsäuren
SG106142A1 (en) Process for the preparation of stabilized polycarbonate
UA38991A (uk) Спосіб термохімічної обробки пласта
CN106565330A (zh) 一种菊花富硒叶面肥
Kurits Investigation of the combined strengthening effect on the stressed state of cylindrical sample(as a model of shaft-type part)